CENBF / CEN Biotech, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

CEN Biotech, Inc.
US ˙ OTCPK

Deler fremragende 65,256,145 shares
Insideraktier33.058.787 shares
Insider ejerskab50,66 %
Total Insiders12
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

0 ( )
7977 out of 10998

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

0.000% ( )
7765 out of 10864

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

CEN Biotech, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
de Lavenu Harold Andre Aubrey Director - [D] 1.623.551 1.623.551
Richard Boswell Senior Executive VP, Director, 10% Owner - [D] [O] [10%] 6.000.000 6.000.000
Byrne Joseph A. President, Director - [D] [O] 164.000 164.000
Chaaban Bahige B. Chief Executive Officer, Director, 10% Owner - [D] [O] [10%] 11.002.432 11.002.432
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Ameen Ferris Vice President*, Director - [D] [O] 1.020.000 1.020.000
Lawrence Lehoux Chief Technology Officer, Director - [D] [O] 3.030.000 3.030.000
Brian Payne Vice President, Director - [D] [O] 2.209.285 2.209.285
Rick Leigh Purdy SVP of Deals and Acquisitions, Director - [D] [O] 2.809.470 2.809.470
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Usamakh Saadikh Director - [D] 1.020.000 1.020.000
Donald Strilchuck Director - [D] 1.361.250 1.361.250
Alex Tarrabain Chief Financial Officer, Director - [D] [O] 2.775.942 2.775.942
Jeffery Allen Thomas Director - [D] 42.857 42.857

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i CENBF / CEN Biotech, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CENBF / CEN Biotech, Inc. Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i CENBF / CEN Biotech, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2021-01-27 Boswell Richard 6.250 0,8000 6.250 0,8000 5.000 215 0.0000 -5.000 -100,00
2021-01-26 Boswell Richard 37.500 0,4000 37.500 0,4000 15.000
2020-02-07 Boswell Richard 8.000 0,8000 8.000 0,8000 6.400
2020-01-06 Boswell Richard 12.500 0,8000 12.500 0,8000 10.000
2019-12-31 Boswell Richard 12.500 0,8000 12.500 0,8000 10.000
2019-11-17 Boswell Richard 25.000 0,8000 25.000 0,8000 20.000
2019-11-17 Boswell Richard 25.000 0,8000 25.000 0,8000 20.000
2019-11-15 Chaaban Bahige B. 228.750 0,7200 228.750 0,7200 164.700
2019-11-15 Chaaban Bahige B. 28.000 0,8000 28.000 0,8000 22.400

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CENBF / CEN Biotech, Inc. Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2022-04-13 2021-12-06 4 Purdy Rick Leigh CENBF Common Stock A - Award D 2.500.000 2.809.470
2021-07-21 3 Lehoux Lawrence CENBF Common Stock D 3.030.000
2021-06-25 2021-06-25 4 Tarrabain Alex CENBF Common Stock A - Award D 1.000.000 2.775.942
2021-06-25 2021-06-16 4 Tarrabain Alex CENBF Common Stock J - Other D 3.000 2.775.942
2021-06-04 2021-04-02 4 Strilchuck Donald CENBF Common Stock A - Award D 341.250 1.361.250
2021-06-04 2021-04-02 4 Aubrey de Lavenu Harold Andre CENBF Common Stock A - Award D 1.041.250 1.623.551
2021-06-03 2021-04-02 4 Saadikh Usamakh CENBF Common Stock A - Award D 1.000.000 1.020.000
2021-06-03 3 Byrne Joseph A. CENBF Common Stock D 1.364.894
2021-06-03 3 Byrne Joseph A. By Spouse CENBF Common Stock I 164.000
2021-06-03 2021-04-02 4 Boswell Richard CENBF Common Stock A - Award D 2.185.679 6.000.000
2021-06-03 2021-01-27 4 Boswell Richard CENBF Common Stock S - Sale D 0,8000 -6.250 -5 6.000.000
2021-06-03 2021-01-26 4 Boswell Richard CENBF Common Stock S - Sale D 0,4000 -37.500 -15 6.000.000
2021-06-03 2021-04-02 4 Payne Brian CENBF Common Stock A - Award D 1.435.000 2.209.285
2021-06-03 2021-04-02 4 Chaaban Bahige B. CENBF Common Stock A - Award D 3.106.122 11.002.432
2021-06-03 2021-04-02 4 Ferris Ameen CENBF Common Stock A - Award D 1.000.000 1.020.000
2021-06-03 2021-05-16 4 Tarrabain Alex CENBF Common Stock J - Other D 3.000 1.772.942
2021-06-03 2021-04-16 4 Tarrabain Alex CENBF Common Stock J - Other D 3.000 1.772.942
2021-06-03 2021-04-10 4 Tarrabain Alex CENBF Common Stock C - Conversion D 1,6000 30.000 48 1.772.942
2021-06-03 2021-04-02 4 Tarrabain Alex CENBF Common Stock A - Award D 300.000 1.772.942
2021-06-03 2021-03-16 4 Tarrabain Alex CENBF Common Stock J - Other D 3.000 1.772.942
2021-06-03 2021-02-16 4 Tarrabain Alex CENBF Common Stock J - Other D 3.000 1.772.942
2021-06-03 2021-01-16 4 Tarrabain Alex CENBF Common Stock J - Other D 3.000 1.772.942
2021-05-28 2017-11-30 5/A Byrne Joseph A. CENBF Common Stock A - Award D 1.250.000 1.353.265
2021-05-28 2017-11-30 5/A Byrne Joseph A. CENBF Common Stock A - Award D 20.000 1.353.265
2021-05-28 2017-11-30 5/A Aubrey de Lavenu Harold Andre CENBF Common Stock A - Award D 20.000 689.571
2021-05-28 2017-11-30 5/A Tarrabain Alex CENBF Common Stock A - Award D 20.000 99.942
2021-05-28 2018-11-15 5 Aubrey de Lavenu Harold Andre CENBF Convertible note J - Other D 1,60 1,6000 -171.632 -275 548.980
2021-05-28 3/A Aubrey de Lavenu Harold Andre CENBF Common Stock D 13.321
2021-05-03 3 Purdy Rick Leigh CENBF Common Stock D 215.720
2021-04-30 3 Thomas Jeffery Allen CENBF Common Stock D 42.857
2021-04-29 2020-02-07 5 Boswell Richard CENBF Common Stock S - Sale D 0,8000 -8.000 -6 3.858.071
2021-04-29 2020-01-06 5 Boswell Richard CENBF Common Stock S - Sale D 0,8000 -12.500 -10 3.858.071
2021-04-29 2020-12-16 5 Tarrabain Alex CENBF Common Stock J - Other D 3.000 1.457.942
2021-04-29 2020-11-16 5 Tarrabain Alex CENBF Common Stock J - Other D 3.000 1.457.942
2021-04-29 2020-10-16 5 Tarrabain Alex CENBF Common Stock J - Other D 3.000 1.457.942
2021-04-29 2020-09-16 5 Tarrabain Alex CENBF Common Stock J - Other D 3.000 1.457.942
2021-04-29 2020-08-16 5 Tarrabain Alex CENBF Common Stock J - Other D 3.000 1.457.942
2021-04-29 2020-07-16 5 Tarrabain Alex CENBF Common Stock J - Other D 3.000 1.457.942
2021-04-29 2020-06-16 5 Tarrabain Alex CENBF Common Stock J - Other D 3.000 1.457.942
2021-04-29 2020-05-16 5 Tarrabain Alex CENBF Common Stock J - Other D 3.000 1.457.942
2021-04-29 2020-04-16 5 Tarrabain Alex CENBF Common Stock J - Other D 3.000 1.457.942
2021-04-29 2020-03-16 5 Tarrabain Alex CENBF Common Stock J - Other D 3.000 1.457.942
2021-04-29 2020-02-16 5 Tarrabain Alex CENBF Common Stock J - Other D 3.000 1.457.942
2021-04-29 2020-01-16 5 Tarrabain Alex CENBF Common Stock J - Other D 3.000 1.457.942
2021-04-28 2019-11-15 5 Chaaban Bahige B. CENBF Common Stock S - Sale D 0,8000 -88.111 -70 7.896.320
2021-04-28 2019-11-15 5 Chaaban Bahige B. CENBF Common Stock S - Sale D 0,7200 -228.750 -165 7.896.320
2021-04-28 2019-11-15 5 Chaaban Bahige B. CENBF Common Stock S - Sale D 0,8000 -28.000 -22 7.896.320
2021-04-28 2019-11-07 5 Chaaban Bahige B. CENBF Common Stock S - Sale D 0,8000 -120.000 -96 7.896.320
2021-04-28 2019-11-07 5 Chaaban Bahige B. CENBF Common Stock S - Sale D 0,8000 -375.000 -300 7.896.320
2021-04-28 2019-11-07 5 Chaaban Bahige B. CENBF Common Stock S - Sale D 0,8000 -178.612 -143 7.896.320
2021-04-28 2019-12-31 5 Boswell Richard CENBF Common Stock S - Sale D 0,8000 -12.500 -10 3.878.571
2021-04-28 2019-11-17 5 Boswell Richard CENBF Common Stock S - Sale D 0,8000 -25.000 -20 3.878.571
2021-04-28 2019-11-17 5 Boswell Richard CENBF Common Stock S - Sale D 0,8000 -25.000 -20 3.878.571
2021-04-28 2019-05-16 5 Boswell Richard CENBF Common Stock S - Sale D 0,1800 -500.000 -90 3.878.571
2021-04-28 2019-04-26 5 Boswell Richard CENBF Common Stock S - Sale D 0,2500 -40.000 -10 3.878.571
2021-04-28 2019-04-26 5 Boswell Richard CENBF Common Stock S - Sale D 0,2500 -60.000 -15 3.878.571
2021-04-28 2019-12-16 5 Tarrabain Alex CENBF Common Stock J - Other D 3.000 1.421.942
2021-04-28 2019-11-16 5 Tarrabain Alex CENBF Common Stock J - Other D 3.000 1.421.942
2021-04-28 2019-10-16 5 Tarrabain Alex CENBF Common Stock J - Other D 3.000 1.421.942
2021-04-28 2019-09-16 5 Tarrabain Alex CENBF Common Stock J - Other D 3.000 1.421.942
2021-04-28 2019-08-16 5 Tarrabain Alex CENBF Common Stock J - Other D 3.000 1.421.942
2021-04-28 2019-07-16 5 Tarrabain Alex CENBF Common Stock J - Other D 3.000 1.421.942
2021-04-28 2019-06-16 5 Tarrabain Alex CENBF Common Stock J - Other D 3.000 1.421.942
2021-04-28 2019-05-16 5 Tarrabain Alex CENBF Common Stock A - Award D 1.250.000 1.421.942
2021-04-28 2019-05-16 5 Tarrabain Alex CENBF Common Stock J - Other D 3.000 1.421.942
2021-04-28 2019-04-16 5 Tarrabain Alex CENBF Common Stock J - Other D 3.000 1.421.942
2021-04-28 2019-03-16 5 Tarrabain Alex CENBF Common Stock J - Other D 3.000 1.421.942
2021-04-28 2019-02-16 5 Tarrabain Alex CENBF Common Stock J - Other D 3.000 1.421.942
2021-04-28 2019-01-16 5 Tarrabain Alex CENBF Common Stock J - Other D 3.000 1.421.942
2021-04-28 2019-12-16 5 Byrne Joseph A. By Spouse CENBF Common Stock J - Other I 4.000 1.497.265
2021-04-28 2019-12-16 5 Byrne Joseph A. CENBF Common Stock J - Other D 2.000 1.497.265
2021-04-28 2019-11-16 5 Byrne Joseph A. By Spouse CENBF Common Stock J - Other I 4.000 1.497.265
2021-04-28 2019-11-16 5 Byrne Joseph A. CENBF Common Stock J - Other D 2.000 1.497.265
2021-04-28 2019-10-16 5 Byrne Joseph A. By Spouse CENBF Common Stock J - Other I 4.000 1.497.265
2021-04-28 2019-10-16 5 Byrne Joseph A. CENBF Common Stock J - Other D 2.000 1.497.265
2021-04-28 2019-09-16 5 Byrne Joseph A. By Spouse CENBF Common Stock J - Other I 4.000 1.497.265
2021-04-28 2019-09-16 5 Byrne Joseph A. CENBF Common Stock J - Other D 2.000 1.497.265
2021-04-28 2019-08-16 5 Byrne Joseph A. By Spouse CENBF Common Stock J - Other I 4.000 1.497.265
2021-04-28 2019-08-16 5 Byrne Joseph A. CENBF Common Stock J - Other D 2.000 1.497.265
2021-04-28 2019-07-16 5 Byrne Joseph A. By Spouse CENBF Common Stock J - Other I 4.000 1.497.265
2021-04-28 2019-07-16 5 Byrne Joseph A. CENBF Common Stock J - Other D 2.000 1.497.265
2021-04-28 2019-06-16 5 Byrne Joseph A. By Spouse CENBF Common Stock J - Other I 4.000 1.497.265
2021-04-28 2019-06-16 5 Byrne Joseph A. CENBF Common Stock J - Other D 2.000 1.497.265
2021-04-28 2019-05-16 5 Byrne Joseph A. By Spouse CENBF Common Stock J - Other I 4.000 1.497.265
2021-04-28 2019-05-16 5 Byrne Joseph A. CENBF Common Stock J - Other D 2.000 1.497.265
2021-04-28 2019-04-16 5 Byrne Joseph A. By Spouse CENBF Common Stock J - Other I 4.000 1.497.265
2021-04-28 2019-04-16 5 Byrne Joseph A. CENBF Common Stock J - Other D 2.000 1.497.265
2021-04-28 2019-03-16 5 Byrne Joseph A. By Spouse CENBF Common Stock J - Other I 4.000 1.497.265
2021-04-28 2019-03-16 5 Byrne Joseph A. CENBF Common Stock J - Other D 2.000 1.497.265
2021-04-28 2019-02-16 5 Byrne Joseph A. By Spouse CENBF Common Stock J - Other I 4.000 1.497.265
2021-04-28 2019-02-16 5 Byrne Joseph A. CENBF Common Stock J - Other D 2.000 1.497.265
2021-04-28 2019-01-16 5 Byrne Joseph A. By Spouse CENBF Common Stock J - Other I 4.000 1.497.265
2021-04-28 2019-01-16 5 Byrne Joseph A. CENBF Common Stock J - Other D 2.000 1.497.265
2021-04-27 2018-12-14 5 Byrne Joseph A. By Spouse CENBF Common Stock J - Other I 4.000 1.425.265
2021-04-27 2018-12-14 5 Byrne Joseph A. CENBF Common Stock J - Other D 2.000 1.425.265
2021-04-27 2018-11-20 5 Byrne Joseph A. By Spouse CENBF Common Stock J - Other I 4.000 1.425.265
2021-04-27 2018-11-20 5 Byrne Joseph A. CENBF Common Stock J - Other D 2.000 1.425.265
2021-04-27 2018-10-17 5 Byrne Joseph A. By Spouse CENBF Common Stock J - Other I 4.000 1.425.265
2021-04-27 2018-10-17 5 Byrne Joseph A. CENBF Common Stock J - Other D 2.000 1.425.265
2021-04-27 2018-09-16 5 Byrne Joseph A. By Spouse CENBF Common Stock J - Other I 4.000 1.425.265
2021-04-27 2018-09-16 5 Byrne Joseph A. CENBF Common Stock J - Other D 2.000 1.425.265
2021-04-27 2018-08-16 5 Byrne Joseph A. By Spouse CENBF Common Stock J - Other I 4.000 1.425.265
2021-04-27 2018-08-16 5 Byrne Joseph A. CENBF Common Stock J - Other D 2.000 1.425.265
2021-04-27 2018-07-16 5 Byrne Joseph A. By Spouse CENBF Common Stock J - Other I 4.000 1.425.265
2021-04-27 2018-07-16 5 Byrne Joseph A. CENBF Common Stock J - Other D 2.000 1.425.265
2021-04-27 2018-06-15 5 Byrne Joseph A. By Spouse CENBF Common Stock J - Other I 4.000 1.425.265
2021-04-27 2018-06-15 5 Byrne Joseph A. CENBF Common Stock J - Other D 2.000 1.425.265
2021-04-27 2018-05-14 5 Byrne Joseph A. By Spouse CENBF Common Stock J - Other I 4.000 1.425.265
2021-04-27 2018-05-14 5 Byrne Joseph A. CENBF Common Stock J - Other D 2.000 1.425.265
2021-04-27 2018-04-17 5 Byrne Joseph A. By Spouse CENBF Common Stock J - Other I 4.000 1.425.265
2021-04-27 2018-04-17 5 Byrne Joseph A. CENBF Common Stock J - Other D 2.000 1.425.265
2021-04-27 2018-03-15 5 Byrne Joseph A. By Spouse CENBF Common Stock J - Other I 4.000 1.425.265
2021-04-27 2018-03-15 5 Byrne Joseph A. CENBF Common Stock J - Other D 2.000 1.425.265
2021-04-27 2018-02-14 5 Byrne Joseph A. By Spouse CENBF Common Stock J - Other I 4.000 1.425.265
2021-04-27 2018-02-14 5 Byrne Joseph A. CENBF Common Stock J - Other D 2.000 1.425.265
2021-04-27 2018-01-14 5 Byrne Joseph A. By Spouse CENBF Common Stock J - Other I 4.000 1.425.265
2021-04-27 2018-01-14 5 Byrne Joseph A. CENBF Common Stock J - Other D 2.000 1.425.265
2021-04-27 2018-12-14 5 Tarrabain Alex CENBF Common Stock J - Other D 3.000 114.571
2021-04-27 2018-11-20 5 Tarrabain Alex CENBF Common Stock J - Other D 3.000 114.571
2021-04-27 2018-10-16 5 Tarrabain Alex CENBF Common Stock J - Other D 3.000 114.571
2021-04-27 2018-09-16 5 Tarrabain Alex CENBF Common Stock J - Other D 3.000 114.571
2021-04-27 2018-08-16 5 Tarrabain Alex CENBF Common Stock J - Other D 3.000 114.571
2021-04-27 2018-07-16 5 Tarrabain Alex CENBF Common Stock J - Other D 3.000 114.571
2021-04-27 2018-06-15 5 Tarrabain Alex CENBF Common Stock J - Other D 3.000 114.571
2021-04-27 2018-05-14 5 Tarrabain Alex CENBF Common Stock J - Other D 3.000 114.571
2021-04-27 2018-04-17 5 Tarrabain Alex CENBF Common Stock J - Other D 3.000 114.571
2021-04-27 2018-03-15 5 Tarrabain Alex CENBF Common Stock J - Other D 3.000 114.571
2021-04-27 2018-02-14 5 Tarrabain Alex CENBF Common Stock J - Other D 3.000 114.571
2021-04-27 2018-01-14 5 Tarrabain Alex CENBF Common Stock J - Other D 3.000 114.571
2021-04-26 2017-11-30 5 Payne Brian CENBF Common Stock A - Award D 20.000 774.285
2021-04-26 2017-11-30 5 Payne Brian CENBF Common Stock A - Award D 750.000 774.285
2021-04-26 2017-11-30 5 Ferris Ameen CENBF Common Stock A - Award D 20.000 20.000
2021-04-26 2017-11-30 5 Strilchuck Donald CENBF Common Stock A - Award D 20.000 1.020.000
2021-04-26 2017-11-30 5 Strilchuck Donald CENBF Common Stock A - Award D 1.000.000 1.020.000
2021-04-26 2017-11-30 5 Aubrey de Lavenu Harold Andre CENBF Common Stock A - Award D 20.000 33.321
2021-04-26 2017-11-30 5 Tarrabain Alex CENBF Common Stock A - Award D 20.000 69.942
2021-04-26 2017-11-30 5 Chaaban Bahige B. CENBF Common Stock A - Award D 20.000 8.914.793
2021-04-26 2017-11-30 5 Chaaban Bahige B. CENBF Common Stock A - Award D 8.750.000 8.914.793
2021-04-26 2017-11-30 5 Byrne Joseph A. CENBF Common Stock A - Award D 1.250.000 1.277.142
2021-04-26 2017-11-30 5 Byrne Joseph A. CENBF Common Stock A - Award D 20.000 1.277.142
2021-04-26 2017-11-30 5 Boswell Richard CENBF Common Stock A - Award D 20.000 4.528.571
2021-04-26 2017-11-30 5 Boswell Richard CENBF Common Stock A - Award D 4.500.000 4.528.571
2021-04-22 3 Chaaban Bahige B. CENBF Common Stock D 144.793
2021-04-22 3 Boswell Richard CENBF Common Stock D 8.571
2021-04-22 3 Saadikh Usamakh CENBF Common Stock D 20.000
2021-04-22 3 Strilchuck Donald CENBF Common Stock D 0
2021-04-22 3 Payne Brian CENBF Common Stock D 4.285
2021-04-22 3 Ferris Ameen CENBF Common Stock D 0
2021-04-22 3 Aubrey de Lavenu Harold Andre CENBF Common Stock D 13.321
2021-04-22 3 Byrne Joseph A. CENBF Common Stock D 12.894
2021-04-22 3 Tarrabain Alex CENBF Common Stock D 49.942
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista